The "Prostate Cancer Biomarkers Market Size and Growth Trends and Companies 2025-2033" has been added to ResearchAndMarkets.com's offering. The Prostate Cancer Biomarkers Market is expected to reach ...

Discover a study revealing how prostate weight influences urinary flow, quality of life, and recovery outcomes in men ...

Well-documented racial inequities exist when it comes to prostate cancer. Extensive research has shown disparities in many measures, including screening, diagnostics, surveillance, and treatment.

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about whether the agent belongs in the first-line setting.

Prostate volume in men with benign prostatic hyperplasia has little effect on the safety and efficacy of GreenLight HPS laser photoselective vaporization prostatectomy (PVP), researchers reported in ...

Discover a study showing TURP combined with TUIBN improves outcomes and reduces complications in small-volume BPH patients.

Pelvic clinical node-positive prostate cancer: Impact of radiotherapy and nodal disease burden. Validation of baseline health-related quality of life as prognostic indicator for survival outcome in ...

A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).